Page last updated: 2024-08-24
toborinone and Cardiomyopathy, Dilated
toborinone has been researched along with Cardiomyopathy, Dilated in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bergin, JD; Cowart, TD; Feldman, AM; Feldman, MD; Haber, HL; Heesch, CM; Johnson, W; Kass, DA; Pak, PH; Powers, ER; Wu, CC | 1 |
Ishihara, H; Iwase, M; Machii, T; Nagata, K; Sobue, T; Yokota, M | 1 |
Trials
2 trial(s) available for toborinone and Cardiomyopathy, Dilated
Article | Year |
---|---|
Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations.
Topics: Blood Pressure; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Rate; Humans; Quinolones; Stroke Volume | 1996 |
Effect of dobutamine and OPC-18790 on diastolic chamber stiffness in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Diastole; Dobutamine; Female; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left | 1997 |